Investors

Financial targets and their archievements

As long-term financial goals, Terveystalo has 5 percent annual revenue growth through organic growth and acquisitions and, in terms of profitability, an adjusted EBITA margin of 12 percent in 2025.

With regard to the capital structure, the target for the net debt/adjusted EBITDA ratio is 3.5x or less. However, indebtedness may temporarily exceed the target level, such as in conjunction with acquisitions. The company also aims to distribute a minimum of 40 percent of net profit as dividends annually. However, the dividend proposal must take into account Terveystalo’s long-term development potential and financial position.

	Growth	Profitability	Capital structure	Dividend
Target	Annual revenue growth of at least 5 percent through organic growth and acquisitions	Adjusted EBITA margin of at least 12 percent in 2025	The net debt/adjusted EBITDA ratio must be 3.5x or less. However, indebtedness may temporarily exceed the target level, such as in conjunction with acquisitions.	The target is to distribute a minimum of 40 percent of net profit as dividends annually. However, the dividend proposal must take into account Terveystalo’s long-term development potential and financial position.
Results in 2023	Terveystalo’s revenue grew by 2.2% to EUR 1,286.4 million.	Terveystalo’s EBITA grew by 19.4% to EUR 125.6 million representing 9.8% of revenue.	Net debt/adjusted EBITDA was 3.0 at the end of 2023.	The Board of Directors proposes that a dividend of EUR 0.30 per share be paid for the financial year 2023. This represents 190.9% of the net result and 63.8% of the adjusted net result for the financial period.